In today’s Pharmaceutical Executive Daily, FDA approves Vybrique for erectile dysfunction, experts argue Phase III clinical ...
FDA has approved Vybrique, the first oral film formulation of sildenafil for the treatment of erectile dysfunction, offering ...
Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX) has secured a US notice of allowance for a continuation patent covering its ...
Polaryx believes the addition of Dr. Berger, Mr. Braun, and Dr. Ryan brings valuable expertise across scientific research, ...
It's not just Botox and IV therapy. The reversal of a COVID rule could upend family and maternal care, mental healthcare ...
DelveInsight's Primary Sclerosing Cholangitis Market Insights report includes a comprehensive understanding of current treatment practices, primary sclerosing cholangitis emerging drugs, market share ...
After decades of misdiagnosis and missed signals, researchers are finally starting to close the gender gap that has long ...
Medicine and professional sports may appear far apart, but both demand extraordinary commitment, personal sacrifice, and ...
The Next Solutions Group (NSG), an award-winning reputation management firm, today announced the launch of NSG Health, a new healthcare division designed to strengthen and formalize the firm's deep ...
“In too many cases, including in California, a slow and inadequate response to wildfires is a direct result of reckless mismanagement and lack of preparedness,” President Donald Trump said last year ...
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results